Skip to content
logo acclivis group
  • About Us
  • News
  • Portfolio
  • Contact Us
Menu
  • About Us
  • News
  • Portfolio
  • Contact Us
mobile menu toggle

News

Loading...
News
July 6, 2021

Just What The Doctor Ordered: Medtech Launches The Ultimate Interoperability Platform

Digital innovation is giving us greater choice and richer experiences in retail, education and even at work. This innovation is also creating exceptional opportunities in healthcare. Health software specialist, Medtech Global, quickly saw an opportunity to help people get more out of their regular doctor’s visits

CONTINUE READING
News
June 23, 2021

Medtech up and running in production with FHIR-based ALEX interop platform

The first third-party application is live in the production environment of ANZ practice management system vendor Medtech Global’s new Application Layer EXchange (ALEX) platform.

CONTINUE READING
News
June 1, 2021

143 – Innovation and interoperability for healthier care; Geoffrey Sayer, Medtech Global

In this episode, we meet Geoffrey Sayer from Medtech Global. Pete and Geoff explore the work that Medtech Global is doing right now, and the journey that brought it here.

CONTINUE READING
News
April 26, 2021

ProCare signs interoperability agreement with Medtech for ALEX integration

Auckland region primary health organisation ProCare has signed an interoperability agreement with GP software vendor Medtech Global as part of Medtech’s FHIR-led integration program.

CONTINUE READING
News
June 3, 2020

Private equity firm buys Medtech Global; ManageMyHealth spun out

The owners of New Zealand's market leading practice management system vendor Medtech Global have sold the business to Australian private equity firm Advent Partners and health technology advisory firm Acclivis for an undisclosed sum, but will retain ownership of its ManageMyHealth personal health platform.

CONTINUE READING

No more pages to load

1 2 Next »

News

Loading...
News
November 19, 2021

Medtech Evolution is Services Australia web services ready

Medtech Global, the provider of the Evolution General Practice Management Systems in Australia and New Zealand, is pleased to announce that Medtech Evolution (Australia) is web services ready after receiving their NOI (Notice of Integration) certification from Services Australia at the end of October 2021.

CONTINUE READING
News
November 15, 2021

PE calls for pharmacy software group Z Software

Specialist private equity investor Acclivis Group has recorded its maiden Australian buyout, snapping up pharmacy management software provider Z Software.

CONTINUE READING
News
September 1, 2021

Medtech has high hopes after buying DrInfo

Both applications will be much more seamless MEDTECH GLOBAL IS PROMISING better integration of its practice management systems with analytics too

CONTINUE READING
News
August 5, 2021

Case Study: Medtech Global

With around 85 percent market share, GP PMS solutions from Auckland-based Medtech Global, are the most widely used in primary care across New Zealand.

CONTINUE READING
News
August 4, 2021

Medtech buys population health and audit tool developer DrInfo

Practice management system vendor Medtech Global has acquired DrInfo, which markets a population health, audit and compliance tool used by over 50 per cent of New Zealand general practices.

CONTINUE READING
News
August 4, 2021

Medtech Global acquires population health and audit tool developer DrInfo

DrInfo supports several practice management system providers by delivering information on enrolments, capitation optimisation, population health targets, among others.

CONTINUE READING
News
July 6, 2021

Just What The Doctor Ordered: Medtech Launches The Ultimate Interoperability Platform

Digital innovation is giving us greater choice and richer experiences in retail, education and even at work. This innovation is also creating exceptional opportunities in healthcare. Health software specialist, Medtech Global, quickly saw an opportunity to help people get more out of their regular doctor’s visits

CONTINUE READING

No more pages to load

1 2 3 Next »
logo acclivis group

Acclivis Group is a private investment and advisory firm exclusively focused on healthcare software and technology companies.

CONTINUE READING
CONTACT US
Linkedin-in
Site map
  • Home
  • About us
  • Portfolio
  • News
  • Contact us
  • Disclaimer
Contact
  • info@acclivis.group
©2025 Acclivis Group. All rights reserved.
  • MADE WITH
  • BY DIGITAL RECIPE

Acclivis Group Management Pty Ltd (CAR) is a corporate authorised representative of Boutique Capital Pty Ltd (BCPL) AFSL 508011, CAR Number 001293067. CAR is the investment manager of the Acclivis Investment I Fund (Fund).

To the extent to which this document contains advice it is general advice only and has been prepared by the CAR for individuals identified as wholesale investors for the purposes of providing a financial product or financial service, under Section 761G or Section 761GA of the Corporations Act 2001 (Cth).

The information herein is presented in summary form and is therefore subject to qualification and further explanation. The information in this document is not intended to be relied upon as advice to investors or potential investors and has been prepared without taking into account personal investment objectives, financial circumstances or particular needs. Recipients of this document are advised to consult their own professional advisers about legal, tax, financial or other matters relevant to the suitability of this information.

The investment summarised in this document is subject to known and unknown risks, some of which are beyond the control of CAR and their directors, employees, advisers or agents. CAR does not guarantee any particular rate of return or the performance of the Fund, nor does CAR and its directors personally guarantee the repayment of capital or any particular tax treatment. Past performance is not indicative of future performance.

The materials contained herein represent a general summary of CAR’s current portfolio construction approach. CAR is not constrained with respect to any investment decision making methodologies and may vary from them materially at its sole discretion and without prior notice to investors. Depending on market conditions and trends , CAR may pursue other objectives or strategies considered appropriate and in the best interest of portfolio performance.

There are risks involved in investing in the CAR’s strategy. All investments carry some level of risk, and there is typically a direct relationship between risk and return. We describe what steps we take to mitigate risk (where possible) in the Fund’s Information Memorandum. It is important to note that despite taking such steps, the CAR cannot mitigate risk completely.

This document was prepared as a private communication to clients and is not intended for public circulation or publication or for the use of any third party, without the approval of CAR. Whilst this report is based on information from sources which CAR considers reliable, its accuracy and completeness cannot be guaranteed. Data is not necessarily audited or independently verified. Any opinions reflect CAR’s judgment at this date and are subject to change. CAR has no obligation to provide revised assessments in the event of changed circumstances. To the extent permitted by law, BCPL, CAR and their directors and employees do not accept any liability for the results of any actions taken or not taken on the basis of information in this report, or for any negligent misstatements, errors or omissions.

This Document is informational purposes only and is not a solicitation for units in the Fund. Application for units in the Fund can only be made via the Fund’s Information Memorandum and Application Form.

white site icon
  • About Us
  • News
  • Portfolio
  • Contact Us
  • About Us
  • News
  • Portfolio
  • Contact Us
  • info@acclivis.group